2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual

Partnering Events:

TechConnect Summit
Clean Technology 2008

NanoSight Limited

J. Warren
NanoSight Limited, UK

Keywords:
instrumentation

Abstract:
Disruptive low cost patented technology for directly visualising and sizing nanoparticles in the size range 10-1,000nm. 100 instruments now sold. First licence sold toSmiths Group plc for Homeland Defence and the environment. Sales made in USA, Japan, Germany, USA, most of Europe. Customers include Unilever, BASF, Roche, Nestle, BP Castrol, Shell, Epson. Extremely efficient use of seed funding to develop and sell two types of instrument. Development started on bioassay for identifying viruses and nanoparticles in the blood with potential partners. Unique potential for a universal in-vitro molecular detector with ultra sensitivity. Lower cost and better performance than existing technology, confirmed by eminent third parties. Wide range of applications across nanotechnology, medical diagnostics, nano-toxicology, oil industry, Homeland Defence, pharmaceutical research and bioscience. Many markets of several £Bn per year, but collectively addressable through the scientific community. Current sales at high gross margins. Clear route to exit; purchase by an instrumentation company or IPO. Funding of up to $2M now sought to build on current successes, develop advanced capabilities and penetrate the US market.


Nanotech 2008 Conference Program Abstract